Gyrase Mutations Are Associated with Variable Levels of Fluoroquinolone Resistance in Mycobacterium tuberculosis

Journal of Clinical Microbiology
Maha R FarhatMegan Murray

Abstract

Molecular diagnostics that rapidly and accurately predict resistance to fluoroquinolone drugs and especially later-generation agents promise to improve treatment outcomes for patients with multidrug-resistant tuberculosis and prevent the spread of disease. Mutations in the gyr genes are known to confer most fluoroquinolone resistance, but knowledge about the effects of gyr mutations on susceptibility to early- versus later-generation fluoroquinolones and about the role of mutation-mutation interactions is limited. Here, we sequenced the full gyrA and gyrB open reading frames in 240 multidrug-resistant and extensively drug-resistant tuberculosis strains and quantified their ofloxacin and moxifloxacin MIC by testing growth at six concentrations for each drug. We constructed a multivariate regression model to assess both the individual mutation effects and interactions on the drug MICs. We found that gyrB mutations contribute to fluoroquinolone resistance both individually and through interactions with gyrA mutations. These effects were statistically significant. In these clinical isolates, several gyrA and gyrB mutations conferred different levels of resistance to ofloxacin and moxifloxacin. Consideration of gyr mutation combinat...Continue Reading

References

May 6, 2003·Nature Biotechnology·Paul HardenbolRonald W Davis
Apr 29, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J TurnidgeG Kronvall
Sep 22, 2007·Drugs·Susanne MoadebiFawziah Marra
Dec 12, 2007·Antimicrobial Agents and Chemotherapy·Charles A PeloquinJohn L Johnson
Feb 13, 2009·PLoS Medicine·Andreas SandgrenMegan B Murray
Jun 10, 2009·Bioinformatics·Heng LiUNKNOWN 1000 Genome Project Data Processing Subgroup
May 28, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Karen R JacobsonMegan B Murray
Sep 10, 2010·The New England Journal of Medicine·Catharina C BoehmeMark D Perkins
Sep 10, 2010·The New England Journal of Medicine·Peter M Small, Madhukar Pai
Dec 15, 2010·Current Protocols in Bioinformatics·Ben Langmead
Mar 19, 2011·Science·Robert J WoodsRichard E Lenski
Jun 3, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·E C Böttger
Feb 24, 2012·The Journal of Antimicrobial Chemotherapy·Frederick A SirgelErik C Böttger
May 4, 2012·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Jun ChenShunqing Xu
Mar 22, 2013·PloS One·Carole D MitnickMercedes C Becerra
Sep 24, 2013·The Journal of Antimicrobial Chemotherapy·Hanna Nebenzahl-GuimaraesMegan B Murray
Jan 25, 2014·The Journal of Antimicrobial Chemotherapy·Silke FeuerriegelStefan Niemann
Sep 2, 2014·Nature Communications·Francesc CollTaane G Clark
Feb 17, 2015·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·M R FarhatK R Jacobson
May 6, 2015·The Journal of Infection·B Molina-MoyaJ Dominguez
Jun 28, 2015·The Lancet Infectious Diseases·Timothy M WalkerUNKNOWN Modernizing Medical Microbiology (MMM) Informatics Group

❮ Previous
Next ❯

Citations

Feb 16, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Karen R JacobsonRobin M Warren
Oct 12, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Maha R FarhatCarole D Mitnick
Sep 7, 2018·Respirology : Official Journal of the Asian Pacific Society of Respirology·Paolo MiottoWing Cheong Yam
Sep 13, 2017·Antimicrobial Agents and Chemotherapy·John Z MetcalfeDavid M Engelthaler
May 17, 2017·Antimicrobial Agents and Chemotherapy·Natasha Van't Boveneind-VrubleuskayaJan-Willem C Alffenaar
Feb 23, 2019·The Journal of Antimicrobial Chemotherapy·Maha R FarhatMegan Murray
Sep 14, 2019·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Majid Faridgohar
Oct 9, 2019·Journal of Applied Microbiology·R SinghT Prasad
Mar 1, 2020·Applied and Environmental Microbiology·Adrián Álvarez-MolinaAvelino Alvarez-Ordóñez
Apr 30, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Fernanda MaruriTimothy R Sterling
Sep 30, 2020·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Pravin Kumar SinghAmita Jain
Jun 15, 2017·American Journal of Respiratory and Critical Care Medicine·John Z MetcalfeDavid M Engelthaler
May 16, 2019·Antimicrobial Agents and Chemotherapy·Marva SeifertTimothy C Rodwell
Feb 13, 2020·Revista Do Instituto De Medicina Tropical De São Paulo·Thales Alves CampeloCristiane Cunha Frota
Mar 24, 2017·The Journal of Antimicrobial Chemotherapy·Devan JaganathPeter R Donald
Feb 1, 2020·Transactions of the Royal Society of Tropical Medicine and Hygiene·Prabha DesikanK S Sachdeva
May 26, 2020·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Andrés-Felipe Villamizar-MogotocoroVladimir V Kouznetsov
Apr 2, 2021·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Jianqin LiangWenping Gong
May 25, 2021·Computational and Structural Biotechnology Journal·Pooja SinghSeyed E Hasnain
May 19, 2021·Antimicrobial Agents and Chemotherapy·Dereje Abate NegatuThomas Dick

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.